A Phase III trial funded by the National Institutes of Health found that quality of life for people with type I diabetes improved dramatically following transplantation of insulin-producing pancreatic islets, according to data published this week in the journal Diabetes Care.
The 48-patient trial involved participants with hypoglycemia unawareness, a condition that renders them unable to sense when their blood sugar drops to a dangerous level.
Get the full story at our sister site, Drug Delivery Business News.